Results 91 to 100 of about 955 (158)

Targeting the p53/xCT/GSH Axis with PRIMA-1<sup>Met</sup> Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia. [PDF]

open access: yesInt J Mol Sci
Pasino M   +21 more
europepmc   +1 more source

PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53. [PDF]

open access: yesBMC Cancer, 2015
Grellety T   +6 more
europepmc   +1 more source

APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase. [PDF]

open access: yesCell Death Dis, 2013
Peng X   +7 more
europepmc   +1 more source

PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinoma. [PDF]

open access: yesFront Mol Biosci, 2023
Paz MM   +9 more
europepmc   +1 more source

Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET. [PDF]

open access: yesProc Natl Acad Sci U S A, 2013
Shalom-Feuerstein R   +8 more
europepmc   +1 more source

Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma. [PDF]

open access: yesBr J Cancer, 2013
Aryee DN   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy